Alpha-7 nicotinic receptor
![](http://upload.wikimedia.org/wikipedia/commons/thumb/f/f2/Icp-lg.jpg/300px-Icp-lg.jpg)
The alpha-7 nicotinic receptor, also known as the α7 receptor, is a type of
It is located in the
permeability.Further, recent work has implicated this receptor as being important for generation of adult mammal neurons in the retina.
Medical relevance
Recent work has demonstrated a potential role in reducing inflammatory neurotoxicity in stroke, myocardial infarction, sepsis, and Alzheimer's disease.[4][5][6]
An α7 nicotinic agonist appears to have positive effects on neurocognition in persons with schizophrenia.[7]
Activation of α7 nicotinic acetylcholine receptor on mast cells, is a mechanism by which nicotine enhances atherosclerosis.[8]
Both
α7-nicotinic receptors also appear to be involved in
Ligands
Agonists
- (+)-N-(1-azabicyclo[2.2.2]oct-3-yl)benzo[b]furan- 2-carboxamide: potent and highly subtype-selective[14]
- Tilorone.
- A-582941: partial agonist; activates
- AR-R17779: full agonist, nootropic
- Amyloid beta: neurotoxic marker of Alzheimer's disease[16]
- TC-1698: subtype-selective; neuroprotective effects via activation of the angiotensin II AT(2) receptor activation[17]
- Bradanicline - partial agonist, in development for treatment of schizophrenia
- Encenicline - partial agonist with nootropic properties, in development for treatment of schizophrenia and Alzheimer's disease [18][19]
- GTS-21 - partial agonist, in development for treatment of schizophrenia and/or Alzheimer's disease
- PHA-543,613 - selective and potent agonist with nootropic properties [20][21]
- PNU-282,987 - selective and potent agonist, but may cause long QT syndrome
- PHA-709829: potent and subtype-selective; robust in vivo efficacy in a rat auditory sensory gating model[22]
- SSR-180,711: partial agonist[24]
- Tropisetron: subtype-selective partial agonist; 5-HT3 receptor antagonist[25]
- WAY-317,538- selective potent full agonist with nootropic and neuroprotective properties
- Anabasine
- Acetylcholine
- Nicotine
- Epiboxidine[26]
- Choline[27]
- ICH-3: subtype-selective partial agonist[28]
Positive allosteric modulators (PAMs)
At least two types of positive allosteric modulators (PAMs) can be distinguished.[29]
- PNU-120,596[30]
- NS-1738: marginal effects on α7 desensitization kinetics; modestly brain-penetrant[31]
- AVL-3288: unlike the above PAMs, AVL-3288 does not affect α7 desensitization kinetics, and is readily brain penetrant. Improves cognitive behavior in animal models[32] In clinical development for cognitive deficits in schizophrenia.
- A-867744[33][34]
- Ivermectin
Other
Antagonists
It is found that
- Anandamide
- α-Bungarotoxin
- α-Conotoxin ArIB[V11L,V16D]: potent and highly subtype-selective; slowly reversible[39]
- β-Caryophyllene[40]
- Bupropion (very weakly)
- Dehydronorketamine
- Ethanol
- Hydroxybupropion (very weakly)
- Hydroxynorketamine
- Ketamine
- Kynurenic acid
- Memantine
- Lobeline
- Methyllycaconitine[20]
- Norketamine
- Quinolizidine (−)-1-epi-207I: α7 subtype preferring blocker[41]
See also
- α3β2-Nicotinic receptor
- α3β4-Nicotinic receptor
- α4β2-Nicotinic receptor
- chaperone proteinfor α7 receptors
- Endocannabinoids
References
- ^ ISBN 0-443-07145-4, 5th ed., Churchill Livingstone 2003) p. 138.
- PMID 28147247.
- S2CID 25872540.
- PMID 21921156.
- PMID 17273548.
- PMID 21368056.
- PMID 16754836.
- PMID 27834689.
- S2CID 17166624.
- PMID 18844224.
- S2CID 17889977.
- PMID 28551702.
- PMID 22359587.
- PMID 15808471.
- PMID 18482100.
- PMID 23776240.
- S2CID 7730290.
- S2CID 19669958.
- ^ "Archived copy" (PDF). Archived from the original (PDF) on 2013-03-19. Retrieved 2014-03-13.
{{cite web}}
: CS1 maint: archived copy as title (link) - ^ S2CID 22477612.
- S2CID 10791918.
- PMID 18490160.
- PMID 17011782.
- PMID 17019409.
- PMID 11212100.
- PMID 22566097.
- ^ González-Rubio, Juana M; Rojo, Jonathan; Tapia, Laura; Maneu, Victoria; Mulet, José; Valor, Luis M.; Criado, Manuel; Sala, Francisco; García, Antonio G. (2004). Borges, R.; Gandía, L. (eds.). Choline as a tool to evaluate nicotinic receptor function in chromaffin cells (PDF). Luis Gandía. Spain: Instituto Teófilo Hernando.
{{cite book}}
:|work=
ignored (help) - S2CID 21407917.
- S2CID 2460247.
- PMID 15858066.
- S2CID 35392171.
- PMID 17470817.
- PMID 19419141.
- S2CID 5470552.
- PMID 11039729.
- S2CID 27825145.
- S2CID 25914087.
- S2CID 23201726.
- PMID 17497892.
- PMID 26965491.
- S2CID 17490742.